Intra-nasal Dexmedetomidine

ApprovedSmall molecule

UUniversity of Massachusetts, Worcester

Intra-nasal Dexmedetomidine is one of 26 small molecule programs targeting Delirium. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DeliriumActive, not recruiting

DeliriumApproved

Active, not recruiting

Competition

Competitive Landscape

167 competitors in Delirium

#DrugCompanyPhaseTrials

Luvox

SSolvay Pharmaceuticals

Phase 3

1 2

Intra-nasal Dexmedetomidine

UUniversity of Massachusetts, Worcester

Approved

1 3

Rozerem

Takeda

Preclinical

6 4

Inapsine

Alnylam Pharmaceuticals

Preclinical

1 5

Anerem

AAcacia Pharma Ltd

Preclinical

7 6

Spravato

WWim Janssens

Preclinical

4 7

Raldesy

PPragma

Preclinical

3 8

Bridion

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

2 9

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

2 10

Methylthioninium Chloride

PProvepharm SAS

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Delirium1 trial

Pediatric Delirium

Enrolling by invitation·UUniversity of Massachusetts, Worcester·Phase 4·NCT04669457·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Intra-nasal Dexmedetomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intra-nasal Dexmedetomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intra-nasal Dexmedetomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Massachusetts, Worcester company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Massachusetts, Worcester

Intra-nasal Dexmedetomidine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Delirium1 trial

References

Drug Info

Quick Facts

Related News